Form4insider filings, from the source

SEC Form 4 · accession 0001127602-18-009729

LEXICON PHARMACEUTICALS, INC. · LXRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Alan J Main
Officer — EVP, Commercial Supply Ops
Period of report
Feb 28, 2018
Accepted (ET)
Mar 2, 2018 · 5:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001062822

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Feb 28, 2018M2,679—A46,909D
Common StockF1Feb 28, 2018M5,272—A52,181D
Common StockF1Feb 28, 2018M4,085—A56,266D
Common StockF1Feb 28, 2018M2,497—A58,763D
Common StockFeb 28, 2018F4,962$8.53D53,801D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF1,F3—Feb 28, 2018M2,679D——Common Stock2,6790D
Restricted Stock UnitsF1,F4—Feb 28, 2018M5,272D——Common Stock5,2725,271D
Restricted Stock UnitsF1,F5—Feb 28, 2018M4,085D——Common Stock4,0858,170D
Restricted Stock UnitsF1,F6—Feb 28, 2018M2,497D——Common Stock2,4977,493D

Explanation of responses